Neogenix Oncology Inc
company.status.inactiveCIK 1341293fmd_19S4Y5A2YS3P77587J1RXW6C4TManufacturing · In Vitro & In Vivo Diagnostic SubstancesTemplate: Standard
Coverage: Jan 01, 2004 to Dec 31, 2011, 12 periods
| Line item | FY2004 | FY2005 | FY2006 | FY2007 | FY2008 | FY2009 | FY2010 | FY2011 |
|---|---|---|---|---|---|---|---|---|
| Research and development | – | – | – | – | – | – | 7 | 7 |
| Operating income | – | – | – | – | – | – | (20) | (20) |
| Interest and investment income | – | – | – | – | – | – | 0 | 0 |
| Other non-operating income (expense) | – | – | – | – | – | – | 0 | 0 |
| Income before taxes | – | – | – | – | – | – | (19) | (19) |
| Net income | (1) | (3) | (4) | (8) | (26) | (36) | (19) | (19) |